Nishimura & Asahi

Japan

Address:
Otemon Tower, 1-1-2 Otemachi
Chiyoda-ku
Tokyo 100-8124
Japan

+81 3 6250 6200





Key contacts:

Partner: Yo Ota
Contact this Practitioner
Partner: Akihiro Hironaka
Contact this Practitioner
Partner: Tsuyoshi Ito
Contact this Practitioner

Quick facts:

Network memberships: Lex Mundi
Languages: Japanese, English, Chinese, Indonesian, German, Vietnamese, Thai, Taiwanese, and more
Recognition: Chambers Asia Pacific 2023 - Tax (Japan): Leading Firm World Tax 2023 - The Comprehensive Guide to the World's Leading Tax Firms: Recommended Firm The Legal 500 Asia Pacific 2023 - Tax (Japan): Tier 1 Best Lawyers in Japan, 2023 edition - Tax: Law Firm of the Year ALB Japan Law Awards 2022: Tax and Trusts Law Firm of the Year


Japan’s Largest International Law Firm:

Nishimura & Asahi is Japan’s largest law firm, covering tax matters in all aspects of domestic and international business and corporate activity. The firm has over 800 Japanese and foreign lawyers- including a former Japanese Supreme Court Justice and scholars—as well as tax accountants and business support professionals.

Cutting-Edge Expertise for Our Clients

We are regarded as a leading tax litigation firm known for our expert handling of complex cases and unparalleled success before Japanese courts and the National Tax Tribunal.

For our clients, we develop and implement creative tax solutions and strategies for M&A transactions, group restructuring, financing arrangements, developing financial products, and other complex transactions.

Our International Presence:

With the continued expansion of our international presence and clientele, the firm has five domestic and 14 overseas offices. Through the firm’s domestic and global networks, we are optimally placed to provide our clients with a full suite of borderless legal services.

 

  • Corporate tax matters
  • Dispute resolution
  • Tax advisory
  • Indirect tax

In 2021, we secured a win in a landmark corporate tax litigation case on behalf of our client Shionogi & Co., a major pharmaceutical company, following a seven-year court battle. The case involved an issue arising from an in-kind contribution of a partnership interest in a cross-border reorganization for the development of a drug to fight AIDS, and the amount of taxable income in dispute was approx. USD 317 million.

TOKYO
OSAKA
NAGOYA
FUKUOKA
SAPPORO

BANGKOK
BEIJING
SHANGHAI
DUBAI
FRANKFURT/DÜSSELDORF
HANOI/HO CHI MINH CITY
JAKARTA*
KUALA LUMPUR*
NEW YORK
SINGAPORE
TAIPEI
YANGON
*Associate offices